Cancer Treatment and Prevention Conference
|Cost and Registration|
Registration fee includes tuition, breakfast, and refreshments (lunch not provided)
Healthcare professionals who work in oncology.
Cancer persists as a major public health challenge throughout the world. The state of Iowa shares many of these cancer-related challenges, but is particularly affected by the presence of radon and local misconceptions regarding vaccinations (IDPH, 2013). Hawes (2018) outlined a clear need for increased uptake of HPV vaccinations as an effective means for cancer control.
The EPA (2018) lists Iowa at the top of its list of states with a high average indoor radon concentration. With radon being the second leading cause of lung cancer, and lung cancer accounting for one quarter of all cancer deaths in the United States, clearly this is an important health issue for the state of Iowa (EPA, 2018). Education of both the general public and of cancer professionals can have a significantly positive impact on these challenges (Worrell, Gibson, & Allen, 2016). These were a few of the major motivating factors that led MercyOne Cancer Center in Des Moines, Iowa, to organize an educational conference focused on cancer treatment and prevention.
- Environmental Protection Agency (EPA) (2018). Health Risk of Radon.
- Hawes, S. E. (2018). HPV vaccination: Increase uptake now to reduce cancer. American Journal of Public Health, 108(1), 23-24. doi:http://dx.doi.org.dmu.idm.oclc.org/10.2105/AJPH.2017.304184
- Iowa Department of Public Health (IDPH) (2013). Radon
- Worrell, J., Gibson, P. & Allen, D. (2016). Radon exposure: Using the spectrum of prevention framework to increase healthcare provider awareness. Clinical Journal of Oncology Nursing, 20(6), 664-666. doi:http://dx.doi.org.dmu.idm.oclc.org/10.1188/16.CJON.664-666
- Discuss actions that can mitigate cancer risks
- Review the importance of HPV vaccination
- Discuss dangers of radon exposure
- List important milestones in the treatment of cancer
- Describe various types of modern medical cancer therapies
Cancer: What Causes It and How Can We Prevent It
Richard Deming, MD, Medical Director, MercyOne Cancer Center
Tim McCoy, DO, Family Medicine, MercyOne Des Moines
Radon in Iowa
Tim McCoy, DO, Family Medicine, MercyOne Des Moines
History of Cancer Treatment
Philip Colletier, MD, Radiation Oncologist, MercyOne
An Overview of Targeted Cancer Therapies
Abdelaziz Elhaddad, MD, Medical Oncology and Hematology Associates, MercyOne
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with commercial interest companies to disclose.
- Nancy Bellville, RN, Planning Committee Member
- Philip Colletier, MD, Speaker
- Mike Curry, MS, DABR, Planning Committee Member
- Richard Deming, MD, Speaker
- Abdelaziz Elhaddad, MD, Speaker
- Tim McCoy, DO, Speaker
- Debbie Meyer, CMD, Planning Committee Member
- Gail Orcutt, MA, Speaker
- Trey Weigand, MHA, Planning Committee Member
- Chris Young, BS, CMD, Activity Director and Planning Committee Member
Continuing Education Credit
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 5.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- MercyOne Des Moines Medical Center is accredited by the Iowa Medical Society (IMS) to provide continuing medical education for physicians. MercyOne Des Moines Medical Center designates this live activity for a maximum of 5.0 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- Nursing Continuing Education: Nurses will be awarded 5.0 contact hours from Mercy Medical Center – Des Moines, Iowa Board of Nursing Provider #17 (pending).
- Medical Dosimetrist Certification Board (MDCB) will award 5.0 continuing education units for medical dosimetrists for full participation. The MDCB is a recognized continuing education evaluation mechanism (RCEEM) for the American Registry of Radiologic Technologists (ARRT), which approves this activity for 5.0 Category A credits (pending).
No commercial interest company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 5.00 AOA Category 1A